Séminaires des Laboratoires de Neurosciences de Marseille Nord

Dans le cadre des séminaires des Laboratoires de Neurosciences de Marseille Nord, nous accueillerons le Dr Elisa Hill-Yardin de Melbourne (Australie) le mardi 27 juin à 13h45 dans la salle de conférences Bât.E RdC de la Faculté de Médecine secteur Nord.

"Towards modulating microbiota in health and disease"

Le Dr Hill exposera les données récentes concernant les interactions entre le microbiote et le système nerveux (axe "cerveau-intestin"). Dans cette perspective, ses travaux sont essentiellement orientés vers l'étude des troubles moteurs digestifs dans l'autisme. 

 

 

Elisa Hill-Yardin | Department of Psychology, RMIT University | Melbourne, Australia

Towards modulating microbiota in health & disease

Dr. Elisa Hill-Yardin is a joint ARC Future Fellow and Vice Chancellor’s Senior Research Fellow at RMIT University, Melbourne, Australia. Her research focuses on how mutations identified in patients with autism affect gastrointestinal function. More recently, this work has led to exciting findings expanding our understanding of how the nervous system interacts with microbes in health and disease. After receiving her PhD in 2001 investigating neurochemical signatures in the mouse neocortex at the Florey Institute of Neuroscience & Mental Health in Melbourne, Dr Hill-Yardin was recruited to the ESPCI ParisTech University as a CNRS Postdoctoral Fellow to study neurophysiological properties of cortical neurons. She returned to Melbourne in 2006 as an NHMRC Howard Florey Centenary Fellow. Dr Hill-Yardin is the recipient of a prestigious US Department of Defense Idea Development Award, as co-ordinating Principal Investigator. She was also awarded the Joliot Chair for French-Australian collaborative projects and the University of Melbourne Dyason Fellowship in 2015 in addition to a CNRS-University of Melbourne collaborative grant in 2016. Dr Hill-Yardin regularly communicates research to the public including via mainstream media and New Scientist Events. She is a founding member and Chair of Frontiers in Neurodevelopmental Disorders (FiND), which enables leading international researchers to engage with scientists, clinicians and families.